Hematology-Oncology Associates of Illinois Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
1999
NCT00004897
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophageal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 5